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Abstract
Background: Alternative RNA processing plays an essential role in shaping cell identity and connectivity in the
central nervous system. This is believed to involve differential regulation of RNA processing in various cell types.
However, in vivo study of cell type-specific post-transcriptional regulation has been a challenge. Here, we describe a
sensitive and stringent method combining genetics and CLIP (crosslinking and immunoprecipitation) to globally
identify regulatory interactions between NOVA and RNA in the mouse spinal cord motoneurons.
Results: We developed a means of undertaking motoneuron-specific CLIP to explore motoneuron-specific protein–
RNA interactions relative to studies of the whole spinal cord in mouse. This allowed us to pinpoint differential RNA
regulation specific to motoneurons, revealing a major role for NOVA in regulating cytoskeleton interactions in
motoneurons. In particular, NOVA specifically promotes the palmitoylated isoform of the cytoskeleton protein
Septin 8 in motoneurons, which enhances dendritic arborization.
Conclusions: Our study demonstrates that cell type-specific RNA regulation is important for fine tuning
motoneuron physiology and highlights the value of defining RNA processing regulation at single cell type
resolution.
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Background
A thorough understanding of the complexities of the mam-
malian central nervous system (CNS) requires detailed
knowledge of its cellular components at the molecular level.
RNA regulation has a central role in establishing cell identity
and function across the numerous cell types in the CNS [1–
7]. Traditional whole tissue-based methods are particularly
limited in their power to delineate cell type-specific RNA
regulation in the mammalian CNS due to its vast cellular di-
versity and architectural complexity. While separation or in-
duction of specific cell types in vitro provides a practical way
for cell type-specific analyses [1–3, 8, 9], alteration of cellular
biology due to loss of physiological contexts presents a sig-
nificant caveat to this approach.
Recent technological breakthroughs using RiboTag and
BAC-TRAP mouse lines have allowed for translational pro-
filing at single cell type resolution [10–13]. These studies
revealed remarkable differences in the population of trans-
lating mRNAs across various CNS cell types, highlighting
the degree of molecular heterogeneity among neuronal
cells. These methods offer important ways to study trans-
lated mRNAs in specific cell types, but do not provide a
way to define other types of cell type-specific RNA regula-
tion. Here we develop a complementary and more general
means to study RNA processing and regulation in a cell
type-specific manner.
RNA processing is regulated by RNA-binding proteins.
Two of the best-studied are NOVA1 and NOVA2,
neuron-specific KH-type RNA-binding proteins that
bind to YCAY motifs and regulate alternative splicing
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and polyadenylation [14–16]. Using crosslinking and im-
munoprecipitation (CLIP), a method that allows strin-
gent purification of protein–RNA complexes captured in
vivo, we identified NOVA targets in mouse neocortex
[16–19], and have estimated that NOVA participates in
the regulation of ~ 7% of brain-specific alternative spli-
cing events in mouse neocortex [20]. Interestingly,
NOVA targets are specifically enriched for transcripts
encoding proteins with synaptic functions—a group of
transcripts that drives CNS cell type diversity [13, 15].
Indeed, NOVA proteins are essential for the function of
multiple neuronal cell types [21–24]. In particular, we pre-
viously uncovered a pivotal role for NOVA in maintaining
spinal motoneuron (MN) survival and physiology [5, 21,
25]. Here, to more precisely define NOVA-regulated RNA
processing in spinal MNs, we developed a new strategy
combining BAC-transgenic mice and CLIP to identify
MN-specific RNA regulation. NOVA targets in MNs were
especially enriched for genes encoding microtubule-,
tubulin-, and cytoskeletal protein-binding proteins. These
results led us to uncover a NOVA-mediated RNA process-
ing event differentially regulated in MNs involving a cyto-
skeleton protein, Septin 8, which controls dendritic
complexity. Cell type-specific CLIP revealed a previously
unidentified role of NOVA in MNs, highlighting the im-
portance of cell type-specific analysis of RNA regulation.
Results
BAC transgenic mice express epitope-tagged NOVA
specifically in motoneurons
Nova1 and Nova2, the two mammalian Nova paralogs,
encode proteins harboring three nearly identical KH-type
RNA binding domains. Nova genes are widely expressed
among various neuronal cell types in the spinal cord, in-
cluding the MNs. For NOVA2, two isoforms arise from al-
ternative translational start sites, which do not shown
detectable RNA binding differences (Yano Y. and Darnell
R. B., unpublished data). Our strategy to study MN-specific
NOVA regulation is twofold—to express AcGFP (Aequorea
coerulescens green fluorescent protein)-tagged NOVA spe-
cifically in MNs, followed by CLIP using antibodies against
the AcGFP epitope tag.
To test if an N-terminal AcGFP tag alters NOVA RNA
binding specificity, we compared global RNA binding
profiles of untagged and AcGFP-tagged long NOVA2
isoform. NIH/3T3 cells ectopically expressing NOVA2 or
AcGFP-NOVA2 were subjected to HITS-CLIP using
antibodies against NOVA and GFP, respectively (Additional
file 1: Supplemental material and methods; Additional file 2:
Figure S1A). We generated complex NOVA:RNA interac-
tomes for both tagged and untagged NOVA2, as defined by
1,775,101 unique CLIP reads for NOVA2 and 9,778,818 for
AcGFP-NOVA2. Both sets of CLIP data showed comparable
genomic distributions (Additional file 2: Figure S1B). We
identified NOVA2 and AcGFP-NOVA2 CLIP peaks, defined
as regions with significantly higher CLIP tag coverage than
gene-specific background expected from uniform random
distribution [26, 27]. The canonical NOVA recognition
motif, YCAY, was enriched around NOVA2 and AcGFP-
tagged NOVA2 CLIP peaks to the same degree (Additional
file 2: Figure S1C, D; R2 = 0.94), with tetramers that may
overlap YCAY by three or more nucleotides (YCAY, NYCA,
CAYN) showing the highest enrichment at both NOVA2
and AcGFP-NOVA2 peaks (red dots in Additional file 2: Fig-
ure S1D). These indicate that the N-terminal AcGFP tag
does not perceptibly alter NOVA2 binding to its cognate
RNA motifs.
Having confirmed the RNA binding fidelity of AcGFP-
tagged NOVA2, we generated transgenic mice express-
ing AcGFP-tagged NOVA2 long isoform under the
MN-specific choline acetyltransferase (Chat) promoter.
The AcGFP-Nova2 cassette was inserted into a bacterial
artificial chromosome (BAC) harboring the Chat pro-
moter through homologous recombination (Fig. 1a) [28].
The engineered BAC was injected into fertilized C57BL/
6 oocytes and two Chat:GFP-Nova2 BAC transgenic
lines, #6 and #17, were selected and maintained from
five original founder lines.
Chat:GFP-Nova2 transgenic mice were born at ex-
pected Mendelian ratios and were phenotypically indis-
tinguishable from wild-type littermates throughout their
lifespan (data not shown). Expression of the GFP-
NOVA2 fusion protein was confirmed in the spinal
cords of both Chat:GFP-Nova2 lines, but not the wild-
type controls (Fig. 1b). To assess the MN-specific
expression pattern of the transgene, we performed im-
munofluorescence staining on spinal cord transverse
sections. GFP-NOVA2 expression was confined to
CHAT-positive neurons in the transgenic lines (Fig. 1c).
Thus, we have successfully established transgenic mouse
lines with epitope-tagged NOVA specifically expressed
in MNs.
HITS-CLIP generates a robust transcriptome-wide NOVA–
RNA interaction map in motoneurons
To define NOVA binding sites in MNs, we undertook
HITS-CLIP on Chat:GFP-Nova2 spinal cords using a mix-
ture of two monoclonal antibodies against GFP to maximize
avidity and specificity. GFP immunoprecipitation was
performed using wild-type or transgenic spinal cords with or
without UV crosslinking, followed by 32P-labeling of bound
RNA. The presence of labeled GFP-NOVA2–RNA com
plexes was dependent on both UV crosslinking and the ex-
pression from the Chat:GFP-Nova2 transgene, further dem-
onstrating the specificity of GFP-NOVA2 CLIP under these
conditions (Fig. 2a, lanes 1–3). Partially digested RNA
crosslinked to GFP-NOVA2 was subjected to subsequent
library preparation steps (Fig. 2a, lane 4; “Methods”).
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Importantly, the production of cDNA was dependent on
reverse transcriptase (Fig. 2b), confirming the absence of
DNA contaminants in the CLIP RNA libraries. cDNA
inserts between 30 and 80 nucleotides (nt; Fig. 2b) were se-
lected for next-generation sequencing (NGS) and further
analysis.
Four sets of biological replicate HITS-CLIP experi-
ments were performed on each Chat:GFP-Nova2 trans-
genic line, with each biological replicate consisting of
pooled spinal cord samples from five to seven 3-
month-old mice. We obtained a total of 2,023,726
unique CLIP reads from these eight biological replicates.
Since AcGFP-Nova2 expression is confined to MNs, we
refer to this group of CLIP reads as MN NOVA CLIP
reads. As a reference to all NOVA binding sites in the
whole spinal cord, we additionally performed four stand-
ard NOVA CLIP experiments on endogenous NOVA1
and NOVA2 in 3-month-old wild-type mouse whole
spinal cords (WSC), generating 17,353,049 unique WSC
NOVA CLIP reads (Additional file 2: Figure S2A;
Additional file 3A). CLIP reads from MN CLIP showed
higher intronic and less exonic distribution compared to
those from WSC CLIP (p = 4.2 × 10− 7; Additional file 2:
Figure S2B).
Fig. 1 BAC-transgenic mouse lines express AcGFP-tagged NOVA2 in MNs. a The generation of recombinant BAC. A-box, a ~ 500-nt sequence
homologous to the mouse Chat 5′ UTR region, mediated the insertion of a plasmid containing GFP-Nova2 coding sequence downstream of Chat
promoter. b Western blot of spinal cord lysate from wild type (WT) mice and mice from Chat:GFP-Nova2 #6 and #17 lines using human anti-
NOVA serum. The 93-kD GFP-NOVA2 was expressed only in transgenic spinal cords. GAPDH was blotted as a loading control. c
Immunofluorescence on spinal cord transverse sections using antibodies against CHAT and GFP, and counterstained with TO-PRO-3. Scale bar
represents 50 μm
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Fig. 2 (See legend on next page.)
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NOVA peaks in MN andWSC CLIP datasets were defined
separately [27]. A total of 25,681 CLIP peaks (p ≤ 0.01) were
identified for MN NOVA CLIP, which harbor CLIP reads
originating from at least four of the eight biological replicates
(biologic complexity (BC) ≥ 4 out of 8; Additional file 3 B)
[16]. In parallel, we identified 218,794 WSC NOVA peaks
represented in at least two out of four biological replicates
(BC≥ 2 out of 4; Additional file 3C). The CLIP data from
our two transgenic lines was highly correlated (R2 = 0.97), as
were WSC CLIP reads (Fig. 2c), underscoring the ability of
cell type-specific HITS-CLIP to reproducibly and quantita-
tively measure in vivo cellular protein–RNA interactions.
MN HITS-CLIP generated a genome-wide binding
profile characteristic of endogenous NOVA proteins.
The canonical NOVA binding motif YCAY was signifi-
cantly and similarly enriched around MN and WSC
CLIP peaks (Fig. 2d). WSC NOVA CLIP peaks mapped
to 12,445 mm9-annotated Entrez genes, including to the
alternative spliced regions of 303 out of 335 known
NOVA-regulated genes (Additional file 3D); MN CLIP
peaks mapped to 4450 Entrez genes, including to 174
known NOVA-regulated alternatively spliced regions
(Additional file 3E) [20]. It is of note that when com-
pared to all NOVA-regulated genes in the WSC, this
subset of MN NOVA targets are especially enriched for
genes encoding microtubule-binding (GO:0008017),
tubulin-binding (GO:0015631), and cytoskeletal protein-
binding proteins (GO:0008092) (hypergeometric test,
false discovery rate (FDR) < 0.05; Fig. 2e and Additional
file 3F), suggesting specialized functions for NOVA–
RNA regulation in MNs.
Since transcript abundance directly affects CLIP signal
intensities, we expected to see higher MN/WSC CLIP
signals on MN-enriched transcripts. Therefore, we tested
whether transcripts known to be enriched in MN, when
compared with WSC, showed enrichment of NOVA
binding in MN NOVA CLIP. The numbers of WSC or
MN CLIP reads within respective peaks were summed
for each gene, followed by analysis using the Bioconduc-
tor edgeR package [29] to identify genes with differential
enrichment of CLIP reads in MN or WSC; 474 and 2434
transcripts showed enriched and depleted NOVA bind-
ing in MN compared to WSC, respectively (FDR ≤ 0.01;
Fig. 2f and Additional file 3G, H). Consistent with the
cell type specificity of GFP-NOVA2 CLIP, the known
MN markers Chat and Chodl were among the top tran-
scripts with the most significantly enriched GFP-
NOVA2 CLIP reads coverage (FDR = 2.61 × 10− 23 and
8.39 × 10− 44, respectively; Fig. 2f ) [30]. Conversely,
Slc6a5, a glycine transporter gene known as an inhibi-
tory neuron marker [31], as well as Erbb4, an interneu-
ron-restricted receptor tyrosine kinase [32, 33], were two
transcripts with the most significantly depleted MN CLIP
reads coverage (FDR = 1.84 × 10− 37 and 2.31 × 10− 31, re-
spectively, Fig. 2f).
We further systematically examined transcripts with
well-defined anatomic expression patterns in spinal cord.
Spinal cord gray matter exhibits a pattern of lamination
consisting of ten laminal layers, with large alpha-MN pools
located in lamina IX [34]. Based on the Allen Spinal Cord
Atlas generated and curated in situ hybridization data [35],
166 transcripts are exclusively expressed in lamina IX, of
which 55 displayed differential NOVA binding (FDR ≤ 0.01)
in MN. Meanwhile, 301 transcripts are restricted in one or
more laminae other than lamina IX, of which 104 showed
significant differential NOVA binding (FDR ≤ 0.01). Among
this group of 159 (55 + 104) transcripts with differential
NOVA binding in MN, the enrichment or depletion of
(See figure on previous page.)
Fig. 2 MN CLIP generated a bona fide and robust MN NOVA binding profile. a Autoradiogram showing NuPAGE separation of radio-labeled GFP-
NOVA2–RNA complexes. Both the transgene and UV crosslinking were required for the presence of radio-labeled GFP-NOVA2–RNA complex
(lanes 1–3), which appeared as a smear from 100 to 125 kD with partial RNase digestion and collapsed to a band around 95 kD in high RNase
concentration (lanes 3 and 4). b Representative RT-PCR polyacrylamide gel images for CLIP library cloning. Left panel shows RT-PCR products at
incremental PCR cycle numbers and right panel shows control reactions without reverse transcriptase. The red box indicates the cDNA (with 5′
and 3′ linkers) size range purified for subsequent cloning and sequencing. c Pairwise correlation of normalized CLIP peak height (PH) between #6
and #17 transgenic lines and between two WSC groups. Normalized PH is the sum of raw CLIP reads in a given peak normalized to the read
depth of each individual experiment. For comparison purpose, CLIP reads in WSC groups were randomly downsampled in the same number of
peaks (27,628) to match the complexity of MN CLIP. d Enrichment of YCAY around CLIP peaks. YCAY enrichment is calculated by normalizing the
number of YCAY motifs starting at a given position relative to all WSC or MN CLIP peaks to the expected YCAY frequency based on random base
distribution. e Molecular function GO enrichment of MNs relative to WSC NOVA targets. FDR values were calculated using hypergeometic test,
followed by Benjamini-Hochberg multiple test correction. The top six GO terms with the smallest FDR values are shown. Horizontal bars shows
significance of GO enrichment, with significantly enriched GO terms in green, and nonenriched in gray. Dashed line marks the FDR value 0.1. f
Volcano plot of gene-wise CLIP read enrichment in MNs versus WSC. Illustration of spinal cord transverse section is shown on the top right corner,
with Rexed laminae I–VIII in purple and lamina IX in green. Genes with a restricted expression pattern in Rexed lamina IX and laminae I–VIII, as
curated by the Allen Spinal Cord Atlas, are shown as green and purple dots, respectively. All other NOVA CLIP targets are displayed as gray circles.
Two MN and two interneuron marker genes are labeled. The numbers of NOVA CLIP targets with enriched or depleted NOVA binding in MNs are
indicated at the upper right and left corners of the chart, respectively, with font colors indicating the Allen Spinal Cord Atlas curated subgroups.
The horizontal blue dashed line denotes FDR value 0.01
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NOVA CLIP signals on these transcripts in MN compared
to WSC were highly concordant with transcript spatial ex-
pression patterns (green and purple dots in Fig. 2f), in that
42 of the 55 (76%) lamina IX enriched transcripts had
enriched NOVA binding in MN (p < 2.2 × 10− 16,
chi-squared test), and 97 out of the 104 (93%) lamina I–
VIII enriched transcripts had lower NOVA binding in MN
(p = 0.007, chi-squared test). Taken together, we conclude
that HITS-CLIP in Chat:GFP-Nova2 lines captured MN-
specific transcriptome-wide NOVA–RNA interactions.
NOVA displays MN-specific binding patterns
We were particularly interested in NOVA binding sites
along a given gene that were disproportionally over- or
under-represented in MNs compared to WSC (Additional
file 2: Figure S3). To identify such NOVA–RNA interac-
tions, we bioinformatically pooled WSC and MN CLIP
reads to define peak regions referred as “joint peaks” (JPs),
and grouped these JPs by genes (Additional file 2: Figure S3
and “Methods”). For each gene with two or more JPs, we
performed pairwise Fisher’s exact test to identify JPs with
disproportionally enriched MN or WSC CLIP reads
(Additional file 2: Figure S3). This subset of JPs denotes
NOVA binding sites over- or under-represented in MN
compared to WSC.
Using this method, we identified 121,216 genic JPs after
performing our peak-finding algorithm on pooled WSC and
MN CLIP reads and filtering for biological reproducibility
(Additional file 2: Figure S3). Analysis of intronic and exonic
JPs as two separate groups revealed 707 (1.07%) over- and
160 (0.24%) under-represented intronic JPs in MNs (Fig. 3a
and Additional file 4A), as well as 1058 (2.34%) over- and
407 (0.90%) under-represented exonic JPs in MNs (FDR ≤
0.1, fold change ≥ 2; Fig. 3b and Additional file 4B). The
AcGFP epitope tag does not significantly account for the ob-
served NOVA binding differences between MN and WSC
(Additional file 2: Figure S4A–C and Fig. 3a, b). Examples of
disproportionally over- and under-represented NOVA bind-
ing sites are shown in Fig. 3c (intronic) and 3d (exonic).
We examined potential RNA sequence signatures
around MN-specific NOVA binding sites (FDR ≤ 0.1, fold
change ≥ 2) by analyzing neighborhood tetramer distribu-
tions. We discovered a marked overrepresentation of poly-
pyrimidine (YYYY) tetramers around intronic NOVA
binding sites over-represented in MN (Fig. 3e), as well as a
striking enrichment of U-rich (two or more uridines) tet-
ramers around 3′-UTR NOVA binding sites over-
represented in MN (Fig. 3f). For both polypyrimidine and
U-rich tetramers, differential enrichment is confined to re-
gions 100 nt up- and downstream of over-represented
MN peaks (Fig. 3e, f ). Interestingly, regions flanking chan-
ged MN peaks are evolutionarily more conserved com-
pared to all intronic or 3′-UTR NOVA peaks (Fig. 3e, f ),
suggesting the potential functional importance of differential
NOVA binding sites in MN. Taken together, these data sug-
gest that a large number of binding sites are differentially
bound by NOVA independent of potential transcript level
variations between WSC and MN, such that NOVA displays
MN-specific binding patterns.
MN-specific NOVA binding predicts MN-specific
alternative splicing
Since NOVA plays an important role in regulating neuronal
transcript splicing, we tested whether MN-specific NOVA
binding correlates with MN-specific alternative splicing. We
took advantage of a high quality MN RNA-seq dataset,
where spinal MNs in 3-month-old wild-type mice were col-
lected by laser capture microdissection (LCM) and subjected
to RNA-seq [36]. For the WSC transcriptome, we performed
RNA-seq on age-, genotype-, and strain background
-matched whole spinal cords. Approximately 36 and 80 mil-
lion mappable reads were obtained from either biological
replicates of MN and WSC RNA-seq, respectively, and alter-
native splicing analysis was performed as described [26]
(http://zhanglab.c2b2.columbia.edu/index.php/Quantas).
Around 30% (1620 out of 5418) of MN-expressed al-
ternative exons showed biologically consistent differen-
tial splicing in MNs compared to WSC (FDR ≤ 0.1, BC =
2 out of 2; Fig. 4a and Additional file 5A). Strikingly, an
even higher proportion of MN-expressed Nova targets
are differentially spliced between MNs and WSC (281
out of 626, 45%, FDR ≤ 0.1, BC2 out of 2; Fig. 4a). The
significant enrichment of Nova targets among exons dif-
ferentially spliced in MNs (p < 2.2 × 10− 16, hypergeo-
metric test) suggests that Nova contributes in an
important way to MN-specific splicing patterns.
We tested whether MN-specific NOVA binding correlated
with MN-specific alternative splicing. Although NOVA bind-
ing in broader regions may influence splice site choice, high
confidence predictions on whether NOVA promotes or re-
presses alternative exons is achieved when NOVA binds
within a window of 400 nt around the regulated exons
[16]—upstream binding highly correlates with splicing
repression, and downstream binding with splicing activation.
Transcriptome wide, 13 NOVA binding sites over- or
under-represented in MNs (FDR ≤ 0.1) are located in these
regulatory “hotspots” around alternative exons with RNA-
seq coverage sufficient for analysis. Interestingly, the majority
of these exons (9 out of 13, 69%) showed MN-specific
splicing patterns (FDR ≤ 0.1). Based on our NOVA–RNA
map, differential NOVA binding patterns in MNs compared
to WSC correctly predicted increase or decrease of alter-
native exon inclusion in MNs compared to WSC for eight
out of the nine alternative exons (89%) (Additional file 5B;
Fig. 4c, d; Additional file 2: Figure S5), consistent with
NOVA mediating a direct action to regulate MN-specific
alternative splicing.
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Fig. 3 NOVA displays MN-specific binding patterns. a, b Pairwise comparison of intronic and exonic relative NOVA peak heights in MNs and WSC
using the method illustrated in Additional file 2:Figure S3. Relative NOVA peak heights in introns or exons are calculated as following: 100 ×
Number of MN or WSC CLIP reads in a JP/Number of MN or WSC CLIP reads in all intronic or exonic JPs in the corresponding gene. NOVA peaks
disproportionally over- or under-represented in MN (FDR≤ 0.1, fold change ≥ 2) are shown in green and purple, respectively. The numbers of
differential peaks and total peaks with sufficient coverage for the analysis are shown in the boxes. c, d UCSC genome browser images illustrating
disproportionally different intronic (c) an exonic (d) NOVA binding sites in MNs. The YCAY track demarcates clusters of NOVA binding motifs. The
WSC and MN CLIP tracks are pooled HITS-CLIP results, normalized for the displayed regions so that the highest unchanged peaks in WSC and MN
share the same height. Significantly different NOVA binding sites between MNs and WSC are marked by arrowheads with FDR values indicated.
UCSC gene annotation and transcript direction are shown at the bottom of each panel. e, f Positional enrichment of YYYY and U-rich tetramers
and phastcons scores around intronic (e) and 3′ UTR (f) NOVA peaks over-represented in MNs, respectively. YYYY and U-rich tetramer enrichment
is calculated from motif frequencies at each base position relative to over-represented (blue or red) or all (black) MN CLIP peaks in introns or 3′
UTRs, normalized by their expected frequencies based on random base distribution. Phastcons scores are plotted with solid dots denoting the
mean phastcons values at a given base position, and lighter lines denoting 95% confidence intervals. Dark gray and brown represent phastcons
scores around all and over-represented intronic/3′ UTR NOVA peaks, respectively. Motif enrichment scales are on the left and phastcons score
scales are on the right. Light gray boxes highlight regions 100 nt around NOVA peaks
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Intriguingly, the seven genes hosting these nine MN-
specific splicing events encode a functionally coherent
set of proteins. Six of the seven gene products, i.e.,
MTSS1, MAP7D1, KIF21A, EPB4.1|3, CLASP1, GPHN,
and KCNC3, are known to interact with cytoskeleton
components (Fig. 4b) [37–43]. For example, MTSS1 binds
to actin monomers and induces membrane protrusion
[37, 44]. Mtss1 harbors two alternatively spliced exons,
E12 and E12a, at the 3′ end of its coding sequence, and
inclusion of E12a, but not E12, is necessary to promote
neuritogenesis [45, 46]. Interestingly, MN CLIP revealed a
unique NOVA binding site 109 nt upstream of Mtss1 E12
in MN (threefold increase in relative peak height; FDR =
0.046; Fig. 4c), which would predict based on the
NOVA-RNA map that NOVA binding would inhibit E12
in MNs. Indeed, we observed a remarkably lower E12 in-
clusion rate in MNs compared to WSC (dI (MN-WSC) =
− 0.69, FDR = 9.65 × 10− 7; Fig. 4c).
Another example is Kcnc3, which encodes a pan-neuronal
voltage-gated potassium channel Kv3.3 [47, 48]. MN CLIP
and RNA-seq revealed a new alternative exon E3a which
showed a significantly higher inclusion rate in MNs com-
pared to WSC (dI (MN-WSC) = 0.05, FDR= 1.38 × 10− 14).
The increased utilization of E3a in MNs positively
Fig. 4 MN-specific NOVA binding correlates with MN-specific
alternative splicing. a Venn diagram showing overlap between
cassette exons differentially spliced in MN and known Nova targets
[20] among all expressed alternative exons (see “Methods”). P value
is calculated by hypergeometric test. b Illustration of cytoskeleton
structures in part of a dendrite and a dendritic spine. Actin filaments
are represented in red, microtubules in green, and spectrin in navy.
Differentially regulated MN NOVA targets are represented in colors
corresponding to their interacting cytoskeletal component(s). c, d
UCSC genome browser images illustrating correlation between
differential NOVA binding and MN-specific alternative splicing in the
cases of Mtss1 E12 (c) and Kcnc3 E3a (d). The YCAY track demarcates
clusters of Nova-binding motifs. WSC and MN RNA-seq tracks are
RNA-seq results from 3-month-old whole spinal cord (this study) and
laser dissected motoneurons [36], respectively, with biological
replicates pooled. For alternative splicing visualization, these two
tracks share the same maximum heights of flanking exons. Exons
differentially spliced (FDR≤ 0.1) in MNs versus WSC are highlighted
in red boxes. The WSC and MN CLIP tracks are pooled HITS-CLIP
results, normalized for the given regions so that the highest
unchanged peaks in WSC and MN share the same height. Read
coverage of RNA-seq and CLIP are scaled on the right axes from
zero to the indicated reads per million. Significantly different NOVA
binding sites between MNs and WSC (FDR≤ 0.1) are marked by
arrowheads. UCSC gene annotation and transcript direction are
shown at the bottom of each panel, with alternative exons marked
in gray. For Mtss1 E12, an increase of the NOVA peak (arrowhead)
immediately upstream in MNs correlates with increased E12b
inclusion in MNs. Similarly, a dramatic increase of NOVA binding
immediately downstream of Kcnc3 E3a (arrowhead) correlates with
activated E3a splicing in MNs
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correlated with a dramatically enhanced NOVA binding
site in MN 121 nt downstream of E3a (fourfold in-
crease, FDR = 4.02 × 10− 7; Fig. 4d). Interestingly, inclu-
sion of E3a would lead to a Kv3.3 isoform with an
extended C-terminal proline-rich domain, which has
been shown to modulate channel inactivation through
triggering actin nucleation at the plasma membrane [43].
Taken together, these observations suggest that unique
NOVA binding patterns around alternative exons in MNs
contribute to MN-specific biology, particularly in shaping
the cytoskeleton and regulating cytoskeleton interactions
in unique ways within spinal cord MNs.
NOVA differentially regulates Sept8 alternative last exon
usage in MNs
Regulation of alternative last exon (ALE) usage involves
intricate interplay between splicing and cleavage/polya-
denylation, two processes both regulated by NOVA [16].
We therefore investigated the potential role that NOVA
played in regulating ALE usage in MNs. Sixty-five ALEs
in 34 genes were differentially included in MNs com-
pared to WSC (FDR ≤ 0.1, |dI| ≥ 0.2; Fig. 5a and Add-
itional file 6A), with the top differentially utilized ALEs
residing in two functionally related genes, Sept8 and
Cdc42 (Fig. 5a) [49–51]. We also examined the pub-
lished Nova2 wild-type and knockout (KO) mouse brain
RNA-seq dataset [24], and identified additional NOVA
regulation on 17 ALEs in 9 genes (FDR ≤ 0.1, |dI| ≥ 0.2,
Fig. 5B and Additional file 6 B). Interestingly, among all
genes with ALEs, Sept8 was the only NOVA target dif-
ferentially regulated in MNs compared to WSC.
Sept8 encodes a family member of the septin proteins,
which are multi-functional components of the cytoskel-
eton [52, 53]. In neurons, septins regulate dendritic and
axon morphology through modulating actin and micro-
tubule dynamics [54–56]. Although much is known
about other septins, SEPT8 is a more recently described
family member and less well characterized. Mouse Sept8
harbors two alternative terminal exons, exon 10a and
10b (Fig. 5c). Four mutually exclusive splice acceptors in
Sept8 exons 10a and 10b can directly join downstream
of exon 9, with splice acceptors 3 in exon 10a and 4 in
exon 10b utilized in > 85% of Sept8 transcripts in adult
mouse spinal cords (Fig. 5c). Comparison of ALE usage
altered between Nova2 wild-type and KO mouse brains
[24] showed markedly lower inclusion rate for exon 10b
in Nova2 KO (dI = 0.42, FDR = 3.32 × 10− 9; Fig. 5c), sug-
gesting that NOVA promotes splice acceptor 4 usage,
exon 10a exclusion, and exon 10b inclusion (Fig. 5c). In
MNs, RNA-Seq data indicate that the majority of Sept8
transcripts use splice acceptor 4 (65% in MNs vs 22% in
WSC), while splice acceptor 3 is preferentially bypassed
(20% in MNs vs 72% in WSC; Fig. 5c). This observed dif-
ferential ALE usage between MNs and WSC coincides
with higher NOVA binding in MNs at three binding
sites located in exon 10a (site A fold change = 10, FDR =
0.0050; site B fold change = 3.4, FDR = 0.0046; site C fold
change = 4.4, FDR = 3.84 × 10− 5; Fig. 5c). NOVA binding
in site C is in a highly conserved YCAY-dense region
encompassing the putative polyadenylation site at the 3′
end of exon 10a (Fig. 5d and Additional file 2: Figure S6A).
NOVA has been shown to prevent cleavage/polyadeny-
lation through binding in close proximity to polyadeny-
lation sites [16]. We tested whether NOVA association
with the 3′ end of Sept8 exon 10a blocked cleavage/
polyadenylation, thus allowing for RNA polymerase II
(PolII) readthrough and inclusion of the downstream
exon 10b. A minigene was constructed using the gen-
omic region of the 3′ end of exon 10a and the 5′ part of
intron 10 (Fig. 5d). We co-transfected this minigene re-
porter with vectors expressing NOVA proteins or con-
trols into COS-1 cells (Additional file 2: Figure S6B),
which lack endogenous NOVA, followed by quantifica-
tion of RNA levels up- and downstream of the E10a
polyadenylation site. In the absence of NOVA proteins,
transcription terminated efficiently at the E10a polyade-
nylation site, as measured by the less than 0.5%
transcription readthrough rate (Fig. 5e). Exogenous
NOVA proteins increased the downstream readthrough
dramatically (> 10%, > 25-fold; Fig. 5e), while another
RNA-binding protein (RBFOX3) showed no effect on
cleavage/polyadenylation at E10a (Fig. 5e), indicating
that NOVA proteins efficiently blocked cleavage/polya-
denylation and promoted downstream transcription.
To test whether direct NOVA association with the YCAY
sites is necessary for the observed regulation, we generated
two mutant minigenes by disrupting YCAY sites while pre-
serving the GC content (Fig. 5d). Mutant 1, with the two
YCAY sites proximal to the E10a poly(A) site mutated,
showed moderately dampened responses (6–11-fold) to
NOVA overexpression (Fig. 5e). In contrast, little NOVA
regulation (less than twofold; Fig. 5e) was observed for mu-
tant 2, where all YCAY sites within 150 nt of the poly(A)
site were disrupted. Taken together, these results suggest
that NOVA promotes Sept8 exon 10b inclusion by binding
close to the polyadenylation site in exon 10a and boosting
readthrough transcription and utilization of exon 10b, and
that strengthened NOVA binding around the exon 10a
poly(A) site in MNs led to higher exon 10b usage observed
in MNs.
The Sept8 exon specifically promoted by NOVA in MNs
encodes a palmitoylated filopodia-inducing motif that
enhances dendritic arborization
Alternative usage of exons 10a and 10b confers the
C-terminal variation between SEPT8 protein isoforms
X5 and X1, respectively. SEPT8 undergoes palmitoyla-
tion in vivo [57], which is a reversible post-translational
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Fig. 5 NOVA promotes Sept8 exon 10b usage in MNs. a, b Volcano plot of differential ALE usage in MNs versus WSC (a) and Nova2 wild type
(WT) versus KO mouse brains (b). ALEs with higher inclusion rates in MNs and Nova2 WT (dI≥ 0.2, FDR ≤ 0.1) are labeled in green and red,
respectively. ALEs with lower inclusion rates in MNs and Nova2 WT (dI≤ 0.2, FDR ≤ 0.1) are labeled in purple and blue, respectively. The blue
horizontal dashed lines denote FDR value 0.1. c UCSC genome browser images illustrating the correlation between differential NOVA binding
pattern and Sept8 ALE usage in MNs. Partial gene and transcript structures of Sept8 are shown on top. Alternative last exons 10a and 10b are
utilized in the X5 and X1 isoforms, respectively. Blue stars mark the two predominant alternative 3′ splice sites used in the adult spinal cord. Red
octagons mark polyadenylation sites. For WSC and MN RNA-seq and NOVA CLIP tracks, see Fig. 4c, d legend for reference. Arrowheads mark
significantly over-represented NOVA binding sites in MNs. E18.5 WT and Nova2 knockout mouse brain RNA-seq are displayed in black. Inclusion of
exon 10b is dependent on NOVA, as highlighted by the orange box. Light gray box marks the genomic region included in the Sept8 minigene in
d. d The Sept8 minigene construct. The 3′ end of Sept8 exon 10a and its adjacent intronic sequence were inserted downstream of the SV40
promoter and upstream of the SV40 poly(A) signal. Double-arrowed segments represent qPCR amplicons used for measuring transcription
readthrough. The region surrounding the poly(A) signal is enlarged, with YCAY motifs marked in navy and the poly(A) signal in red. Mutant 1
minigene lacks the two YCAY motifs proximal to the poly(A) signal. The mutant 2 minigene is devoid of YCAY in the 150-nt region surrounding
the poly(A) signal. e Sept8 minigene assay. COS-1 cells expressing minigene variants and indicated proteins were harvested for RNA isolation and
qRT-PCR analysis. Two amplicons illustrated in Fig. 5d were used to measure RNA levels up- and downstream of exon 10a poly(A) sites,
respectively. Y-axis represents percentage of downstream relative to upstream transcript level. Error bars represent standard error of the mean
(SEM) based on three independent replicates
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process of attaching a 16-carbon saturated fatty acid to
cysteine residues [58]. Although the definitive palmitoy-
lation site(s) in SEPT8 is unknown, the only predicted
sites are two exon 10b-encoded cysteine residues (C469,
C470) in the NOVA-promoted SEPT8-X1 isoform [59].
To assess whether C469 and C470 mediate SEPT8-X1 pal-
mitoylation, we expressed SEPT8 isoforms in COS-1 cells
and employed the acyl-resin-assisted-capture (acyl-RAC)
assay for palmitoylation detection [60, 61]. This assay
relies on the indirect capture of palmitoylated proteins
facilitated by palmitoyl-ester-specific cleavage (Additional
file 2: Figure S7A). Whereas acyl-RAC failed to detect any
palmitoylated SEPT8-X5, 5–10% of SEPT8-X1 was shown
to be palmitoylated, as evidenced by the presence of
SEPT8-X1 in the resin captured fraction (Fig. 6a, lane 2).
This capture was dependent on palmitoyl-ester-specific
cleavage (Fig. 6a, lanes 3 and 4). Mutations in C469 and
C470 (SEPT8-X1-mut, C469S/C470S) prevented the de-
tection of SEPT8-X1 palmitoylation (Fig. 6a), indicating
that the two cysteines encoded by the NOVA-promoted
exon 10b are the sites for palmitoyl addition. The data
here collectively suggest that NOVA-regulated alternative
RNA processing in MNs mediates isoform-specific SEPT8
palmitoylation.
Interestingly, we discovered that Sept8 exon 10b en-
codes a potential filopodia-inducing motif (FIM), charac-
terized by two adjacent palmitoylated cysteines (C469,
C470) and nearby basic residues (R475, R480) (Fig. 6a,
orange box) [62]. It has been shown that the palmitoy-
lated FIM was sufficient to promote dendritic branching
and spine formation in neurons [62]. To assay the func-
tional effects of SEPT8-X1 on dendritic morphology, we
performed isoform-specific knockdown (KD) using a
construct co-expressing GFP and an shRNA targeting
Sept8 exon 10b (shX1) in primary mouse hippocampal
neurons which express SEPT8-X1 (Additional file 2:
Figure S7B). KD efficiency (79%) and isoform specificity
of shX1 was demonstrated in COS-1 cells expressing ex-
ogenous SEPT8-X1 and X5 (Additional file 2: Figure S7C).
Compared to neurons expressing the control scramble
shRNA, neurons transfected with shX1 had significantly
less complex dendritic arbors, as indicated by an 82%
reduction in the number of dendritic branching points
(Fig. 6b, e; p = 2.9 × 10− 9). Meanwhile, total dendritic
length showed a 65% reduction (p = 9.2 × 10− 11), and sholl
analysis revealed a similar 66% reduction in critical value
in neurons with SEPT8-X1 KD (Fig. 6e; p = 4.4 × 10− 10).
Even more strikingly, SEPT8-X1 KD led to an almost
complete absence of dendritic spines—dendrites became
smooth with a few focal swellings at distal ends (Fig. 6b, f;
p =7.0 × 10− 82). These abnormalities were partially res-
cued by co-expression of the shRNA-resistant SEPT8-X1,
but not SEPT8-X5 or the palmitoylation-deficient SEPT8-
X1-mut (Fig. 6c, e, f ). Therefore, we conclude that
SEPT8-X1 promotes dendritic branching and spine for-
mation through its palmitoylated FIM.
Since NOVA promotes the SEPT8-X1 isoform, we pre-
dicted that neurons lacking NOVA would exhibit a simi-
lar reduction in dendrite arbor and spine density. We
knocked down NOVA2 using an shRNA (shNova2)
which efficiently depleted 76% of the endogenous NOVA2
in N2A cells (Additional file 2: Figure S7D). Similar to
SEPT8-X1 KD, neurons depleted of NOVA2 displayed
greatly decreased dendritic arbors compared to control
shRNA transfected neurons, as evidenced by a 55% reduc-
tion in the number of dendritic branching points, a 47%
reduction in total dendritic length, and a 48% reduction in
the sholl analysis critical value (Fig. 6b, e; p = 3.6 × 10− 7,
2.5 × 10− 7, 1.8 × 10− 7, respectively). On the other hand, to
our surprise, NOVA2 knockdown did not significantly
affect dendritic spine density (Fig. 6b, f ). Co-expression of
SEPT8-X1, but not the two non-palmitoylated variants,
partially restored dendritic arbor complexity in neurons
with NOVA2 KD (Fig. 6d, e), suggesting that NOVA2 en-
hances dendritic arborization through promoting the
FIM-containing SEPT8 isoform.
Discussion
Understanding brain function involves understanding its
parts, as demonstrated by the discovery of differences in
ribosome-associated transcripts by looking at specific
neuronal cell types in the basal ganglia (D1 vs D2 neu-
rons) [12]. Here we develop a general method combining
BAC-transgenic engineering and CLIP that is conceptu-
ally applicable to the study of any protein–RNA interac-
tions within specific cell types. We apply this strategy to
analyze differential NOVA binding in mouse spinal
MNs, compare that to interactions visible at the gross
level of whole spinal cord analysis, and uncover
NOVA-regulated biology specific to MNs. MN-specific
CLIP revealed a major role for NOVA in regulating cyto-
skeleton interactions in MNs, a function obscured in
previous whole tissue-based analyses. This led us to dis-
cover a consequent defect in dendritic morphology in
neurons lacking NOVA, which may help explain in part
the severe MN defect seen in NOVA1/2 double KO
MNs [21].
MN-specific CLIP unmasks previously undetected aspects
of NOVA function
MNs are among the largest neurons in the central ner-
vous system. Their distinct morphology, characterized
by a long axon and intricate dendritic arbor, renders
traditional cell purifications based on enzymatic tissue
digestion and cell purification methods particularly un-
satisfactory for understanding the molecular biology of
the whole neuron, especially given abundant evidence
for RNA localization within the dendritic arbor. The cell
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type-specific CLIP strategy developed here allows robust
and quantitative identification of NOVA binding sites in
MNs in vivo, in both the cell bodies and processes. This
generated a transcriptome-wide NOVA–RNA inter-
action atlas in MNs with NOVA binding sites in over
4000 genes. NOVA binding in MNs reflects MN
Fig. 6 NOVA-dependent SEPT8 isoform promotes dendritic arborization and spine morphogenesis. a Detection of palmitoylated SEPT8-X1 by
acyl-RAC (as illustrated in Additional file 2:Figure S7A). Top: C-terminal amino acid sequence of SEPT8-X1. Orange box highlights the FIM, with
green letters marking palmitoylated cysteines and nearby basic amino acid residues. C469 and C470 were mutated to serine residues in SEPT8-X1-
mut. Bottom: COS-1 cells expressing HA-tagged SEPT8 variants were used for the acyl-RAC assay. Immunoblotting of supernatant and thiopropyl-
sepharose captured fractions using an antibody against HA is shown. Ten percent of supernatants were loaded compared to the captured
fractions. b–d Representative maximum projected confocal images of hippocampal neurons expressing shRNAs and HA-tagged SEPT8 or controls.
GFP, which is co-expressed from the shRNA constructs, is used as a neurite tracer. Anti-HA labels exogenously expressed SEPT8 variants.
Representative images of dendrites are shown at the bottom of each panel. Scale bar represents 100 μm. e, f Boxplots evaluating dendritic arbor
complexity (e) and dendritic spine density (f) in neurons with SEPT8-X1 or NOVA2 KD and SEPT8 rescue. Number of dendritic branching points,
total dendritic lengths, and sholl analysis critical values are plotted in e, and number of dendritic spines per 100 μm is plotted in f. Measurements
in neurons expressing the control, shX1, and shNova2 shRNAs are highlighted by the gray, pink, and blue boxes, respectively. Quantification was
based on 15–17 neurons per group
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transcriptome signatures, which further demonstrated
the cell type specificity of our assay.
The cell type-specific CLIP strategy developed here
allowed delineation of a subset of MN NOVA targets
from WSC. These MN NOVA targets are enriched in
genes encoding synaptic functions to a similar extent
compared to WSC NOVA targets, yet they are especially
enriched in genes encoding cytoskeleton interacting pro-
teins. Enrichment of MN versus WSC CLIP signals in
this subset of genes is significant even when adjusted to
MN/WSC transcript level differences (p < 2.2 × 10− 16;
Additional file 2: Figure S8), suggesting that these gene
ontology (GO) enriched NOVA target genes contain
quantitatively strengthened NOVA binding sites in MNs
compared to WSC. Furthermore, through combining cell
type-specific CLIP with MN transcriptome profiling, we
discovered RNA processing events differentially regu-
lated by NOVA in MNs. Around 2% of NOVA binding
sites were over- or under-represented in MNs, which is
consistent with our findings that ~ 2% (eight alterna-
tively splicing regions out of 303) of NOVA-regulated al-
ternative splicing showed MN-specific splicing patterns
correctly predicted by MN-specific NOVA binding.
Interestingly, the vast majority of these events also reside
in transcripts encoding cytoskeleton-interacting proteins.
These findings reveal a previously undiscovered cell
type-specific role for NOVA in regulating MN cell
biology.
NOVA plays an important role in regulating MN
cytoskeleton interactions
The top NOVA-regulated ALE was in Sept8, which en-
codes a member of the multifunctional septin family that
is capable of regulating neurite outgrowth and branching
through interactions with cytoskeleton components [54–
56]. NOVA binding at the polyadenylation site in Sept8
exon 10a correlated with exon 10b usage, and this was
only evident in analysis of MN CLIP, not WSC CLIP
alone. Consistent with prior observations of position-
dependent effects of NOVA on APA [16], we demon-
strated that NOVA directly inhibits cleavage/polyadeny-
lation by binding close to the exon 10a poly(A) site,
presumably promoting exon 10b transcription and
splicing. Interestingly, the NOVA-dependent exon 10b
encodes an FIM capable of promoting dendritic branching
and spine formation. Indeed, we discovered that SEPT8-X1,
the NOVA-dependent SEPT8 isoform harboring the FIM,
specifically promotes dendritic arborization and spine for-
mation. Moreover, we found that neurons lacking NOVA2
displayed decreased dendritic arbors, which are partially
rescued by SEPT8-X1. Taken together, these data indicate
that NOVA promotes dendritic arborization through Sept8
regulation.
While SEPT8-X1 promotes dendritic spine formation,
we were not able to detect changes in dendritic spine
density in NOVA2 KD neurons. This may be related to
insufficient effects from NOVA2 KD, or from contribut-
ing indirect factors, such as NOVA promotion of protein
isoforms with antagonistic effects on spine formation.
For example, based on in silico palmitoylation site pre-
diction [59], we identified a total of eight NOVA targets
where a predicted FIM is regulated by NOVA. Of these
eight genes, NOVA promotes the FIM-harboring iso-
form in four (Sept8, Ccp110, Sdccag3, and Ccdc84), while
inhibiting the FIM-encoding exon in the other four
(Sgce, Clip1, Kcnma1, and Ube2e2). It is possible that
changes of various NOVA targets upon NOVA KD miti-
gate the overall effect on dendritic spine density.
We have previously shown that NOVA proteins play
an essential role in MN physiology [21]. MNs in mice
lacking both Nova family members were paralyzed
and failed to cluster acetyl-choline receptors at the
neuromuscular junctions [21]. Successful rescue of
the neuromuscular junction defect was evident after
Nova-knockout MNs were engineered to constitutively
express the Nova-regulated Z+ alternatively spliced
isoform of agrin, but surprisingly remained paralyzed.
Phrenic nerve stimulation revealed that the axonal
synaptic machinery for conducting action potentials
and synaptic vesicle release from the axon was func-
tional, leading to the conclusion that dysregulation of
additional MN NOVA RNA targets contribute to a
proximal physiologic defect in Nova-KO MNs. Here,
MN-specific CLIP reveals a major role of NOVA in regu-
lating the MN cytoskeleton, including promoting dendritic
complexity. Dendrites are the main information-receiving
sites of neurons. Spinal MNs, as the gateway controllers of
the CNS motor outputs, have elaborate dendritic struc-
tures to meet the highly complex demand of precisely co-
ordinating muscle contractions spatially and temporally
[63, 64]. Early and progressive dendritic degeneration has
been reported in lower MNs in MN disease mouse models
as well as amyotrophic lateral sclerosis (ALS) patients [65,
66], suggesting the importance of dendritic integrity to
MN function. Our new findings may provide additional
avenues for understanding the role that NOVA and RNA
regulation plays in MN function.
Differential NOVA binding sites in MN suggests
combinatorial control of multiple RNA-binding proteins
When we compared the NOVA–RNA interactions in
MNs and WSC, we uncovered over 2000 sites transcrip-
tome-wide that are differentially bound by NOVA in
MNs compared to WSC. In this way cell-specific CLIP
offers the possibility of revealing cell type-specific regu-
latory phenomena that are otherwise obscured from ana-
lysis of whole tissues. What underlies this unique NOVA
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binding profile in MNs? It has been shown that com-
binatorial control is integral in RNA processing regula-
tion. Cellular RNA-binding protein networks play a
pivotal role in determining target selection and binding
dynamics of a given RNA-binding protein [67]. For
NOVA, interactions with PTBP2, the neuronal polypyri-
midine tract binding protein, as well as RBFOX proteins
have previously been demonstrated [20, 68]. In particu-
lar, we have shown that PTBP2 interacts with and antag-
onizes NOVA in the regulation of glycine receptor alpha
2 subunit (Glra2) splicing [68]. Interestingly, compared
to all NOVA binding sites, sequences around NOVA
bindings sites that are over-represented in MNs showed
enrichment of pyrimidine-rich motifs and higher evolu-
tionary conservation (Fig. 3e, f ). This sequence signature
around MN-specific NOVA binding sites along with lower
PTBP2 levels in MNs [36] suggests the hypothesis that
lower abundance of PTBP2 in MNs allows for unmasking
of certain NOVA binding sites that are otherwise occupied
by PTBP2 in other neurons. This kind of intricate cell
type-specific interaction network may help determine
Nova target selection beyond the specificity determined
by sequence and structural constraints.
Cell type-specific CLIP
Cell type-specific CLIP is in general applicable to any cell
type and a great variety of RNA-binding proteins. The
current study is neuron-specific due to the nature of Nova
[25, 69], but a further array of cell types within the CNS or
other tissues can be studied in vivo through epitope tag-
ging. Indeed, Schaefer and colleagues used a similar strategy
to identify AGO-bound miRNAs in D2 neurons of the
mouse striatum [70], and Camk2a-neurons in the forebrain
[71]. And as CLIP is applied to identify functional protein–
RNA interactions defining the actions of an increasing
number of RNA-binding proteins, including splicing factors
[19], RNA-editing factors [72], and epigenetic regulators
[73], expanding aspects of post-transcriptional and RNA-
related regulation can be investigated in a cell type-specific
manner. We recently described a method, PAPERCLIP, in
which PABPC1 CLIP was used to identify brain-specific
transcripts and alternative 3′ UTR processing within those
cells [74]. Combining a cell-specific tagging strategy
with PAPERCLIP would allow profiling of cell-specific
polyadenylated transcripts in the brain or within any
tissue, an approach that would complement the delin-
eation of ribosome-associated transcripts demarcated
by BAC-TRAP.
We examined whether GFP-NOVA2 expression in our
BAC-transgenic MNs could have affected our observa-
tions relative to unperturbed neurons. The BAC-trans
genic system has intrinsic expression biases and might,
for example, have skewed the MN NOVA-PTBP ratios,
impacting the observed NOVA binding increases around
pyrimidine-rich regions. However, the high concordance
between NOVA binding changes in our transgenic MNs
and differential splicing in MNs without exogenous
NOVA strongly argues for the physiological relevance of
our transgenic model. A more elegant approach of study-
ing cell type-specific RNA–protein interactions would be
to generate conditionally epitope-tagged knock-in lines
followed by the introduction of a cell type-specific Cre re-
combinase expression. Epitope-tagged protein would be
expressed in the desired cell type from its endogenous
promoter, thus preserving protein stoichiometry; this
strategy has already shown promise with the ubiquitous
RNA-binding protein PABPC1 [75].
Caution should be taken when comparing cell type-
specific RNA binding profiles across different cell types or
tissues. One issue is that differences in CLIP library
complexities between comparison groups may lead to un-
equal statistical power in identifying over- versus under-
represented binding sites. In our case, although we pooled
spinal cords from multiple transgenic mice per biological
replicate and performed twice as many biological replicates
as the WSC CLIP, we were only able to generate less than
one-eighth of CLIP reads from MN-specific CLIP com-
pared to WSC CLIP. This is likely due to low abundance of
MN-specific GFP-NOVA2 compared to the WSC NOVA
pool (Fig. 1b). We hypothesize that the unevenness of
library complexities contributed to the identification
of a high percentage (> 72%) of NOVA binding sites
significantly over-represented in MNs compared to WSC
(Fig. 3a, b). We predict that achieving higher MN CLIP li-
brary complexity by including more BC and/or pooling
more samples per BC can alleviate this bias.
Another challenge of analyzing cell type-specific CLIP
data involves obtaining the matching cell type-specific
transcriptomes, which is essential for teasing out func-
tionally important protein–RNA interactions. A variety
of technologies, such as fluorescence-activated cell sort-
ing, LCM, and TRAP-seq can be explored for this pur-
pose. We utilized a published RNA-seq dataset on laser
captured MNs for the MN-specific transcriptome. Our
transcriptome reference for WSC NOVA CLIP, on the
other hand, is less than ideal. Since NOVA expression is
restricted in neurons, the ideal dataset would be
neuron-specific transcriptome profiling generated using
technologies such as TRAP-seq or cTag PAPERCLIP.
Cell type-specific CLIP may be relevant for the study
of many neurological diseases, such as ALS and ataxias,
where defined cell types are pathologically affected dur-
ing the entire course or the initial stages of disease pro-
gression. Interplay between the affected cells and their
cellular context plays an important role in disease
progression [76–79]. Our strategy allows for in vivo dis-
section of both cell autonomous and non-autonomous
effects resulting from disease-causing mutations or
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insults, which had not been possible before. Great in-
sights on cell type contributions to disease pathogenesis
will be gained upon application of this strategy to a var-
iety of animal models.
Conclusions
Here we demonstrate the feasibility and physiological
relevance of delineating neuronal cell type-specific RNA
regulation. Through cell type-specific epitope tagging of
the RNA-binding protein NOVA2, we generated a
MN-specific NOVA–RNA interaction map using CLIP.
Cell type-specific CLIP revealed a major role of NOVA
in regulating cytoskeleton interactions in MNs, including
promoting the palmitoylated isoform of a cytoskeleton
protein, Septin 8, which enhances dendritic arbor com-
plexity. MN-specific NOVA binding predicts MN-
specific alternative RNA processing, further supporting
the idea that cell type-specific RNA regulation contrib-
utes to cell identity. Our study highlights a non-incre-
mental gain of knowledge moving from whole tissue- to
single cell type-based RNA regulation analysis. As our
strategy for cell type-specific CLIP is highly adaptable,
we envision wide application of this method in a variety
CNS cell types as well as disease models.
Methods
Antibodies and dilutions
The following antibodies were used in CLIP experiments:
anti-GFP mouse monoclonal antibodies 19F7 and 19C8
(Memorial Sloan Kettering Monoclonal Antibody Facility),
anti-NOVA serum from a paraneoplastic opsoclonus-
myoclonus ataxia (POMA) patient. The following anti-
bodies and dilutions were used for immunoblotting:
anti-NOVA patient serum (1:2000), mouse anti-GAPDH
monoclonal antibody 6C5 (Abcam, 1:20,000), rabbit anti-
RBFOX3 (1:500) [80], rabbit anti-HA monoclonal antibody
C29F4 (Cell Signaling Technology, 1:100). The following
antibodies and dilutions were used for immunofluorescence:
rat anti-GFP monoclonal antibody (nacalai tesque, 1:1000),
goat anti-GFP polyclonal antibody (Rockland, 1:500), goat
anti-CHAT polyclonal antibody (EMD Millipore, 1:500),
rabbit anti-HA monoclonal antibody C29F4 (Cell Signaling
Technology, 1:1000), rabbit anti-SEPT8 monoclonal antibody
(pan SEPT8, EPR16099, 1:200), mouse anti-SEPT8_X1
monoclonal antibody D-11 (Santa Cruz, 1:50), chicken
anti-MAP2 antibody (Thermo Fisher Scientific, 1:1000).
Cell culture and transfection
NIH3T3 and COS-1 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% heat-inactivated fetal bovine serum, 100 U/mL peni-
cillin, and 100 μg/mL streptomycin. NIH3T3 and COS-1
cells were transfected with plasmid constructs using
lipofectamine 2000 (Invitrogen), according to the manu-
facturer’s instructions.
Mouse hippocampal neurons were isolated from 18-
day-old CD1 mouse embryos and cultured in 24-well
plates according to established protocols. For shRNA
knockdown and rescue experiments, 0.4 μg of shRNA
vector and 0.6 μg of protein expressing vector or control
were transfected at DIV 10 using 3 μL of NeuroMag fol-
lowing the manufacturer’s protocol. Transfected neurons
were fixed at DIV 12 for immunofluorescence staining
and confocal imaging (see below).
Construction of BAC-transgenic mouse lines expressing
GFP-NOVA2 in MNs
In brief, AcGFP-fused Nova2 coding sequence was
cloned into a pLD53.SC2 plasmid. Subsequently, a DNA
fragment homologous to Chat 5′ UTR region was PCR
amplified using primers GCCAGGCATCTGAGAGGC
and CCTAGCGATTCTTAATCCAGAGTAGCAGAGC
TG and inserted into the plasmid through blunt end
ligation at AgeI site. The sequence of the resulting plas-
mid pLD53.SC2-AcGFP-Nova2 was confirmed by Sanger
sequencing and deposited to the Addgene database.
Recombinant BAC was generated using RP23-246B12
and pSC2-GFP-Nova2 as described previously [81] and
microinjected into pronuclear oocytes of C57BL/6 mice
from Charles River. By PCR genotyping, nine mice from
68 offspring were confirmed to carry the transgene. Two
founders, #6 and #17, were bred with C57BL/6 mice
from Charles River to establish stable transgenic lines.
Immunofluorescence staining
Paraformaldehyde-fixed spinal cords were transversely
sectioned at 14 μm thickness and kept at − 80 °C. Before
immunofluorescence staining, sections were rehydrated
in PBS for 10 min, followed by a 1-h block in blocking
buffer containing 100 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 0.2% Triton X-100, 5% horse serum. Primary anti-
bodies diluted in blocking buffer were subsequently
added to the sections followed by overnight incubation at
room temperature. Secondary antibody hybridization and
TO-PRO-3 staining were performed using Alexa Fluor
conjugated antibodies diluted in 100 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 0.2% Triton X-100 with 1 μM
TO-PRO-3. Confocal images were taken using an inverted
LSM 510 laser scanning confocal microscope (Zeiss).
For immunofluorescence staining on hippocampal
neurons, cells were fixed in 4% paraformaldehyde at
room temperature for 10 minutes, permeabilized with
0.1% Triton-X 100 in PBS at room temperature for 15
minutes, and blocked in PBS containing 0.1% Tween-20
and 10% donkey serum for 1 h at room temperature.
The primary antibodies, diluted in PBS containing 1%
BSA and 0.1% Tween-20, were added to the cells and
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incubated overnight at room temperature. Alexa Fluor
conjugated secondary antibodies (Jackson Immunore-
search) were used at 1:500 dilution to detect either the
tag epitope or proteins of interest. Confocal images were
taken using an inverted LSM 880 NLO laser scanning
confocal microscope (Zeiss).
HITS-CLIP experiments and analysis
Spinal cords were hydraulically extruded in Hank’s Bal-
anced Salt Solution (HBSS) and triturated seven times
with a 21½ gauge needle in 10 mL HBSS. Immediately
after trituration, tissue suspensions were crosslinked
400 mJ/cm2 three times at 0 °C. Crosslinked tissues were
collected by centrifugation at 4000 g for 2 minutes.
HITS-CLIP experiments were performed as previously
described [16, 26] with PCR primers specified in Add-
itional file 7. For MN-specific CLIP, 400 μL of Dyna-
beads protein G (Invitrogen) precoated with 50 μg of
each anti-GFP monoclonal antibody (mAb) was used to
immunoprecipitate GFP-NOVA2 in UV crosslinked
spinal cord lysate pooled from five to seven 3-month-old
BAC-transgenic mice. For WSC CLIP, 400 μL of Dyna-
beads protein G precoated with 80 μL of human
anti-NOVA serum was used to immunoprecipitate lysate
from one 3-month-old wild-type mouse spinal cord.
cDNA libraries were prepared as previously described
and sequenced on an Illumina Genome Analyzer IIx,
HiSeq 1000 or HiSeq 2000.
Bioinformatic processing and mapping of CLIP NGS
reads were performed similarly as previously described
with slight modifications [18, 80, 82, 83]. Specifically, we
removed the 3′ linker sequence from CLIP reads before
mapping the remaining sequences to the mm9 build of
the mouse genome with novoalign (http://www.novo-
craft.com) without iterative trimming using parameters
–t 85 -l 25 -s 0 -o Native -r None. Following mapping,
pentamer frequencies immediately downstream of CLIP
reads were ranked. CLIP reads immediately upstream of
the top 20 pentamers with zero or one mismatch to
GTGTC were removed. We have recently discovered
that under our reverse transcription (RT) conditions, the
3′ end of the RT primer could prime reverse transcription
by hybridizing to GUGUC or similar pentamers in the
CLIPed RNA, leading to their preferential amplification
(Park C., personal communication). Bioinformatically re-
moving such reads circumvents this technical caveat.
NOVA binding peaks were defined as previously de-
scribed using gene regions compiled from refseq, UCSC
known genes, and ESTs plus their downstream 10 kb as
transcription units [26, 27, 80]. Gene regions with Entrez
IDs were referred to as known genes. Defined peaks
were then filtered for biological complexity, requiring
CLIP reads from at least half of the biological replicates.
Joint peaks (JPs), in particular, were defined by running
the peak finding algorithm using CLIP reads pooled
from both comparison groups (e.g., MNs and WSC), and
requiring CLIP reads from at least half of the biological
replicates in either group (i.e., WSC BC 2 out of 4 or
MN BC 4 out of 8).
Gene-wise CLIP read enrichment between WSC and
MNs was evaluated using the Bioconductor edgeR pack-
age with tagwise dispersion model [29]. P values of dif-
ferential NOVA binding on specific sites were calculated
using Fisher’s exact test on the following 2 × 2 matrix:
m M‐m
n N‐n
where m and n stand for the number of MN and WSC
CLIP reads in a given JP, respectively, while M and N
stand for the total number of intronic/exonic MN and
WSC CLIP reads within all intronic/exonic JPs in the
corresponding transcript, respectively. Coverage is de-
fined as the smallest number among the 2 × 2 matrix.
Benjamini-Hochberg multiple-testing correction was
performed using all intronic or exonic JPs with a mini-
mum coverage of 10.
RNA-seq library preparation and data analysis
We performed WSC RNA-seq on two biological repli-
cates of 3-month-old SOD1WT transgenic mice in SJL/
B6 mixed background. For each replicate, poly(A) se-
lected RNA from spinal cord was used to prepare
RNA-seq library using an Illumina TruSeq RNA sample
prep kit. We generated 100-nt paired-end reads using an
Illumina Genome Analyzer II. In order to compare WSC
and MN RNA-seq, we trimmed our WSC reads to 74 nt
to match the read length of the MN RNA-seq dataset by
Bandyopadhyay et al. (GSE38820). Both WSC and MN
datasets were mapped to the mouse (mm9) genome and
exon junctions using OLego with default parameters
(15-nt seed with 1 nt overlapping, four or fewer mis-
matches per read) [84]. Only reads unambiguously
mapped to the genome or exon junctions were retained
for downstream analysis. For MN RNA-seq, 36,484,398
and 38,293,208 NGS reads were mapped for the two bio-
logical replicates, respectively, while 74,444,847 and
81,175,598 NGS reads were mapped for WSC RNA-seq
replicates. Transcript level and alternative splicing
analyses were performed as previously described.
Bioconductor edgeR package was used to evaluate statis-
tical significance of transcript level differences between
WSC and MNs [29]. Fisher’s exact test was used to cal-
culate p values of differential alternative splicing, and
the FDR was estimated using the Benjamini-Hochberg
method. Alternative exon splicing was analyzed as de-
scribed [26]. Alternative exons with splice junction read
coverage over 10 [26] were considered “expressed”, and
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were included in Benjamini-Hochberg multiple test cor-
rection. Differential alternative splicing events were
identified by requiring FDR ≤ 0.1 in addition to biological
consistency (BC2 out of 2).
Gene ontology analysis
GO analysis was performed using GOrilla by running
unranked lists of target and background genes [85]. For
background genes, we used all genes with rpkm ≥ 1 in
WSC or MNs.
Motif enrichment analysis
For motif enrichment around differential MN intronic
NOVA peaks, tetramer occurrences 100 nt around the
center of each peak were counted and compared to
those 100 nt around all intronic or exonic NOVA peaks
using a hypergeometric test.
Sept8 minigene assay
To construct the Sept8 minigene, the C57BL/6 genomic re-
gion amplified with primers TACGACTCACTATAGG
GCGAATTCGGATCCGCATGAATTCTGACCCCTGTG
A and CAATAAACAAGTTCTGCTTTAATAAGATCTC
CGTAACCTGGCTACCAGTGA was cloned into BamHI
and BglII digested pSG5 vector using HIFI DNA assembly
kit (New England Biolabs). Mutant minigenes were con-
structed by assembling the PCR amplified vector backbone
(forward, TTGGGCAGTAGCTTCGCTG; reverse, TAAC
ATAACAGAGAAGCAAGCTGGCT) with synthetic
gBlocks (IDT DNA) carrying the desired mutations.
Minigene (1 μg) was co-transfected into COS-1 cells with
1 μg of control vector or NOVA/RBFOX3 expression vec-
tor. Cells were harvested 48 h post-transfection for im-
munoblotting or RT-qPCR following standard protocols.
Primers CTGACCCCGCATATGTTCCTGTGT and CAA
GCTGGCTATCCTGGGCCTCTT were used to amplify
an exon 10a region, while primers GTCTGCGATGGTTT
TGCAGAGGTG and GGCCACAGGAAATGGAGAT
GTGAG were used for an intron 10 amplicon. Three
independent experiments were performed for statistical
comparison.
Acyl-RAC assay
We seeded 250,000 COS-1 cells per well in six-well
plates and transfected them with 2 μg of constructs ex-
pressing FLAG-HA-tagged SEPT8 variants 18–24 h
later. Acyl-RAC assay was performed using the CAPUR-
Eome S-Palmitoylated Protein Kit (Badrilla) according to
the manufacturer’s protocol. Treated protein lysates
were subsequently immunoblotted with rabbit anti-HA
antibody.
Image analysis
Maximum projected confocal images were produced using
ImageJ using only linear adjustments. Dendrites were
semi-automatically traced using the Simple Neurite Tracer
plugin. Critical value and number of dendritic branching
points were deduced by using the “sholl analysis” and
“analyze skeleton” plugins. Fifteen to 17 neurons were an-
alyzed per group.
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